# EDGAR Filing Document

**Accession Number:** 0001438423
**File Stem:** 0001209191-23-016956
**Filing Date:** 2023-3
**Character Count:** 9024
**Document Hash:** c7cad16735f0bc9dfc756aa0623dce1f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001209191-23-016956.hdr.sgml**: 20230307

**ACCESSION NUMBER**: 0001209191-23-016956

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230228

**FILED AS OF DATE**: 20230307

**DATE AS OF CHANGE**: 20230307

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Schrenk David
- **CENTRAL INDEX KEY:** 0001968509

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37900
- **FILM NUMBER:** 23714319

**MAIL ADDRESS:**
- **STREET 1:** C/O EVERSPIN TECHNOLOGIES, INC.
- **STREET 2:** 5670 CHANDLER BOULEVARD, SUITE 130
- **CITY:** CHANDLER
- **STATE:** AZ
- **ZIP:** 85226
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** EVERSPIN TECHNOLOGIES INC
- **CENTRAL INDEX KEY:** 0001438423
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **IRS NUMBER:** 262640654
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 5670 W. CHANDLER BOULEVARD
- **STREET 2:** SUITE 100
- **CITY:** CHANDLER
- **STATE:** AZ
- **ZIP:** 85226
- **BUSINESS PHONE:** 480-347-1111

**MAIL ADDRESS:**
- **STREET 1:** 5670 W. CHANDLER BOULEVARD
- **STREET 2:** SUITE 100
- **CITY:** CHANDLER
- **STATE:** AZ
- **ZIP:** 85226

## Ex-24

```

POWER OF ATTORNEY

Know all by these presents that the undersigned hereby constitutes and appoints
each of Anuj Aggarwal, Anthony Griff and Matt Hemington, signing individually,
the undersigned's true and lawful attorneys-in fact and agents to:

(1)	execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer, director and/or more than 10% stockholder of Everspin
Technologies, Inc. (the "Company"), Forms 3, 4, and 5 in accordance with Section
16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2)		do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4, or 5,
complete and execute any amendment or amendments thereto, and timely file such
form with the SEC and any stock exchange or similar authority; and

(3)	take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney in fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney in fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney in fact may approve in such
attorney in fact's discretion.

	The undersigned hereby grants to each such attorney in fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney in fact, or such attorney
in fact's substitute or substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and powers herein granted.  The
undersigned acknowledges that the foregoing attorneys in fact, in serving in
such capacity at the request of the undersigned, are not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned's holdings of and transactions in securities
issued by the Company, (b) revocation by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact or (c) as to any attorney-in-fact
individually, until such attorney-in-fact is no longer employed by the Company
or Cooley LLP.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 6 day of March, 2023.

	/s/  David Schrenk
	David Schrenk

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Schrenk David<br><sub>(Last) (First) (Middle)</sub><br>C/O EVERSPIN TECHNOLOGIES, INC.<br>5670 W. CHANDLER BOULEVARD, SUITE 130<br><sub>(Street)</sub><br>CHANDLER, AZ 85226<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>EVERSPIN TECHNOLOGIES INC [ MRAM ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-02-28 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_VP Sales and Business_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 24609<sup>(1)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Stock Option (Right to Buy) | <sup>(2)</sup> | 2028-08-19 | Common Stock | 2110 | $8.52 | D |  |
| Stock Option (Right to Buy) | <sup>(3)</sup> | 2029-08-25 | Common Stock | 3057 | $6.86 | D |  |
| Stock Option (Right to Buy) | <sup>(4)</sup> | 2030-03-23 | Common Stock | 7292 | $2.23 | D |  |
| Stock Option (Right to Buy) | <sup>(5)</sup> | 2030-04-06 | Common Stock | 1209 | $2.56 | D |  |
| Stock Option (Right to Buy) | <sup>(6)</sup> | 2031-08-05 | Common Stock | 12500 | $5.62 | D |  |
| Stock Option (Right to Buy) | <sup>(7)</sup> | 2032-03-13 | Common Stock | 15000 | $8.17 | D |  |

---

### Footnotes:

(1) Includes 22,043 shares subject to unvested restricted stock units.

(2) Fully vested.

(3) The option vested as to 25% of the shares on August 26, 2020, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on August 26, 2023.  The original grant was for 6,986 shares, of which 3,929 shares have been exercised.

(4) The option vested as to 25% of the shares on March 24, 2021, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on March 24, 2024.  The original grant was for 12,500 shares, of which 5,208 shares have been exercised.

(5) The option vested as to 25% of the shares on April 7, 2021, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on April 7, 2024.  The original grant was for 2,000 shares, of which 791 shares have been exercised.

(6) The option vested as to 25% of the shares on March 10, 2022, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on March 10, 2025.

(7) The option vested as to 25% of the shares on February 28, 2023, and the remainder vest in 36 equal monthly increments thereafter. The option becomes fully exercisable on February 28, 2026.

**Signature:** /s/ Anthony Griff, Attorney-in-Fact  
**Date:** 2023-03-07

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**